Today’s AI Top Pick: GPI
8/3/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live GPI price forecast →
Group 1 Automotive (GPI) is the cleanest multi-timeframe setup in this pool with the best risk/reward at today's print of $278.01. Every single timeframe is pointing the same direction: 1h fc +8.4%, 4h fc +19.1/+28.1/+35.8%, 1d fc +21.3/+33.9/+39.9%, and 1wk fc +8.4/+6.5/+12.7%. Crucially, GPI is sitting at 0% position-in-21bar-range on ALL FOUR timeframes with a -22.3% daily and -22.2% weekly drawdown from highs — you are buying deep dip, not chasing extension. bullish_prob = 1.0 and near_term_bullish = 1.0 confirms the tape. Fundamentals are the strongest 'value + growth' combo here after MORN: PE 11.96, fwdPe 6.32, PEG 0.77, ROE 9.4%, recom 1.8, instOwn 98.35%, and analyst targetUpsidePct 40.6%. Unlike MORN, which trades at 100% of range on both 4h and 1wk (already ran +11.6% post-earnings), GPI has the pullback already baked in — the JP Morgan downgrade and weak Q2 earnings on 8/1 are the exact reason the drawdown exists, and the Simply Wall St. piece explicitly frames it as 'undervalued after weak earnings and the Hennessy deal.' The bad news is priced; the forecast tape is telling you the reversion trade sets up now. Compare vs the runner-ups: TASK has excellent 4h forecasts (+76% long) but is pinned at 100% of 1h/4h range (chase risk). MORN's fundamentals are elite (fund_score 7.25) but 1h/4h forecasts are NEGATIVE (-9.2%, -4.9%) after the earnings pop — buy the pullback, not the top. IDR has good near forecasts but weekly is -82% long (deteriorating). LBRDA has clean TF alignment but weaker fundamentals (fund_score 2.25, negative ROE). GPI uniquely combines: cheap valuation + all TFs bullish + at range lows + high institutional ownership + strong-buy analyst tilt. Today is the entry because the technical drawdown from the earnings sell-off has already flushed weak hands to 0% of range across every timeframe, and the forecast model is calling for +33% on 1d mid horizon. Waiting risks the mean-reversion bounce starting without you; the -22% drawdown provides a defined risk envelope with clear invalidation.

- JP Morgan downgrade on 8/1/2026 signals sell-side momentum against the name; further downgrades could cap upside
- Q2 earnings were weak (Simply Wall St. framed as 'weak earnings'); if auto-retail cycle deteriorates further, fwdPe 6.32 could re-rate down
- Debt/Equity 1.96 is elevated — sensitive to rate environment and any dealer-floorplan stress
- Profit margin only 1.29% means small revenue misses translate to large EPS misses (operating leverage cuts both ways)
- Short float 8.55% is moderate but could accelerate downside if $260 breaks
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | GPI | BUY NOW | 8.6 | All 4 TFs bullish, 0% of range on every TF, fwdPe 6.32 with PEG 0.77 — cleanest dip-buy in the pool. |
| 2 | TASK | BUY PULLBACK | 7.9 | Cheap (fwdPe 3.95) with 4h fc +76% long, but at 100% of 1h/4h range — wait for retest of $5.60. |
| 3 | LBRDA | BUY NOW | 7.4 | Clean multi-TF alignment with 1wk fc +151% long and fwdPe 5.61; deep weekly drawdown offers reversion setup. |
| 4 | MORN | BUY PULLBACK | 7.2 | Best fund_score (7.25) but at 100% of 4h/1wk range post-earnings pop — 1h/4h fc negative, wait for $180s. |
| 5 | IDR | BUY PULLBACK | 6.8 | Strong fund (ROE 27%, profit margin 43%) with near-term fc +14-51%, but 1wk fc -82% long is a red flag. |
| 6 | TNXP | BUY PULLBACK | 6.4 | TONMYA Medicare coverage catalyst plus huge weekly forecast, but shortFloat 22.56% and negative margins caution. |
| 7 | IDN | BUY PULLBACK | 6.3 | bullish_prob 1.0 with 1h fc +142% and RSI 31 oversold, but weekly forecast negative shows deteriorating trend. |
| 8 | USLM | WAIT | 6.0 | Great fund_score 6.75 but Q2 EPS miss and 1wk fc -36% long argue for patience. |
| 9 | CSV | BUY PULLBACK | 5.9 | Solid fund_score 6.25 with sector peer SCI beating; wait for earnings clarity. |
| 10 | QNTM | BUY PULLBACK | 5.7 | Strong forecasts across TFs (+134% 1d long) and near_term_bullish 1.0, but -984% ROE and micro-cap risk. |
| 11 | GRCE | BUY PULLBACK | 5.6 | FDA no clinical deficiencies is a real catalyst; RSI 30.55 oversold with 4h fc +65% long. |
| 12 | INDP | BUY PULLBACK | 5.5 | Deep -66% drawdown with 1d fc +226% long and near_term_bullish 1.0; speculative reversion. |
| 13 | GLMD | WAIT | 5.5 | Positive Aramchol pipeline news but near_term_bullish only 0.2; forecasts modest. |
| 14 | DRMA | BUY PULLBACK | 5.4 | 1wk fc +6524% is a model outlier; 1d fc +237% long more credible, near_term_bullish 1.0. |
| 15 | LTRN | BUY PULLBACK | 5.4 | EMA Phase 1b/2 clearance is positive catalyst; forecasts constructive but drawdown deep. |
| 16 | AKTX | WAIT | 5.3 | Maxim $30 target and Whitehawk collab positive, but 1wk forecast -100% across all horizons is disqualifying. |
| 17 | XTLB | BUY PULLBACK | 5.3 | 1wk fc +138% long with near_term_bullish 1.0; tiny float micro-cap speculation. |
| 18 | TGEN | BUY PULLBACK | 5.2 | $8M backlog news is positive; 4h fc +82% but 1wk fc -48% long shows conflict. |
| 19 | BCDA | WAIT | 5.1 | 1wk fc +280% long attractive but near_term_bullish only 0.4 and salesYoY -100%. |
| 20 | PRSO | BUY PULLBACK | 5.0 | 1wk fc +369% long with near_term_bullish 1.0, but salesYoY -40.57% deteriorating. |
| 21 | CNCK | AVOID | 4.8 | Resale prospectus for 56M shares is a dilution overhang; fwdPe 1333 absurd. |
| 22 | FRMM | WAIT | 4.7 | shortFloat 48.16% and profitMargin -5489% are red flags; limited TF coverage. |
| 23 | NXL | WAIT | 4.6 | salesYoY +110% but profitMargin -3023% and micro-float too risky. |
| 24 | WW | AVOID | 4.4 | Only 1d data, bullish_prob null, debtEq 1.76 with declining sales — broken thesis. |
| 25 | USBC | AVOID | 4.4 | near_term_bullish 0, 1d fc -25% short, targetUpside 12400% is unreliable data. |
| 26 | YCBD | WAIT | 4.3 | bullish_prob 0.6 and near_term 0.4 both weak; micro-cap with limited catalyst. |
| 27 | LUCY | AVOID | 4.1 | $3M warrant exercise dilution 7/8, recom 3.0 (hold), profitMargin -272%. |
| 28 | IPWR | AVOID | 4.0 | $75M shelf prospectus is a dilution landmine on top of ps 2025 and profit margin -44730%. |
| 29 | NXTC | AVOID | 3.9 | Reverse merger with Avere plus $320M PIPE is massive dilution; equity holders relegated to CVR. |
| 30 | INTZ | AVOID | 3.7 | Zacks flagged bigger fall than market twice in past week; declining trend with profitMargin -169%. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord